profit from every $100 of sales.

Semler Scientific
We have no price for Semler Scientific since 21 January 2026. It may have been taken over, merged or renamed, so the figures below are from then.
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
You pay $7.60 for every $1 of profit it makes in a year.
It holds more cash than debt.
Semler Scientific vs. similar companies
Semler Scientific grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
Semler Scientific | 7.6× · Cheap | ||
Boston Scientific | 22.2× · Fair price | ||
Koninklijke Philips | 30.1× · Expensive | ||
Steris | 32.8× · Expensive | ||
Zimmer Biomet Holdings | 27.7× · Fair price |
AI analysis
An AI analyst reads Semler Scientific's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- 7.6×
- –
- 0.27
- 0.7×
- 5.5×
- –
- –
- -53.2%
- 13.2%
- 0.0%
Profitability
- 90.8%
- -94.7%
- 130.8%
- -126.2%
- -4.6%
- 31.3%
- 15.6%
- 8.1%
- -6.1%
- 12.7%
Growth
- +9.9%
- +27.7%
- −1,073.1%
- –
- +2.4%
Financial health
- -2.3×
- 0.25
- 19.5%
- -9.6×
- 1.97
- 1.95
- 0.06
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
What analysts expect
- Average price target
- $50.50
- Range
- $40.00 – $61.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Feb 17, 2026 | 3.41 | -0.54 | +731.5% |
| Nov 12, 2025 | 1.07 | 0.04 | +2,575.0% |
| Aug 4, 2025 | 5.04 | -0.10 | +5,140.0% |
| May 13, 2025 | -0.76 | – | – |
| Feb 18, 2025 | 3.41 | 0.26 | +1,211.5% |
| Nov 4, 2024 | 0.72 | 0.37 | +94.6% |
| Aug 5, 2024 | 0.64 | 0.56 | +14.3% |
| May 7, 2024 | 0.78 | 1.03 | −24.3% |
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
6/7Passes 6 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Questions about Semler Scientific
Is Semler Scientific a good stock to buy?
A strong, very profitable business, and the price looks low. 6 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Semler Scientific AI analysis
What does Semler Scientific do?
Semler Scientific, Inc. develops and delivers cutting-edge technology solutions aimed at boosting the clinical effectiveness and operational efficiency of medical professionals throughout the United States. It is in Medical - Devices.
Does Semler Scientific pay a dividend?
No. Semler Scientific does not pay a dividend at the moment.
Is Semler Scientific stock halal?
Yes. Semler Scientific passes our halal screen: its business is permitted and its debt is 0% of its market value, under the 30% limit. How we check
Who are Semler Scientific's competitors?
The largest listed companies in the same industry are Boston Scientific, Koninklijke Philips, Steris and Zimmer Biomet Holdings. The peers table on this page compares their profit, growth and price with Semler Scientific's.
Prices: daily closes to Jan 21, 2026. Fundamentals: company reports via invest-like data.



